We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Medicines Agency issued the first report on its open access policy for clinical data submitted by sponsors in their marketing applications for new drugs. Read More
A federal court issued a preliminary injunction against Dr. Reddy’s generics for Indivior’s addiction treatment Suboxone (buprenorphine and naloxone) pending the outcome of a patent challenge. Read More
A new report from four Democratic senators claims contacts between Novartis and President Donald Trump’s former personal attorney and Novartis were more extensive than previously disclosed. Read More
DOJ said the altered limits will incentivize opioid manufacturers to step up their vigilance on potential misuses of their products and better equip the DEA to respond to the addiction crisis, while in the meantime ensuring those opioids that are necessary for medical and research needs remain available. Read More